TEAM

Our team has significant experience with strategy formulation, transaction execution and valuation as both advisors and business operators.

Scott Chesky

Scott Chesky scott@cheskypartners.com https://www.linkedin.com/in/scottchesky

MANAGING PARTNER

Scott has spent the majority of his career in investment banking, primarily focused on merger and acquisition advisory for middle-market healthcare & business services companies. He has advised clients on a wide variety of strategic transactions ranging in value from less than $1 million to over $1 billion.

Scott also has significant corporate strategy and operating experience, having served as Executive Vice President of InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. In this role, he was responsible for development and execution of the company’s strategic direction through acquisitions, creation of new lines of business and formation of strategic partnerships. Scott was also an integral part of the senior management team and administered the full range of typical day-to-day operating issues faced by middle-market companies. In addition, Scott was the chief architect of InfuSystem’s response to the Centers for Medicare & Medicaid Services’ Competitive Bidding Program for durable medical equipment providers, which resulted in the company winning contracts in all nine eligible geographical areas.

Scott has previous experience analyzing potential investments for a venture capital firm and as the director of finance for a private, grant-making foundation. Scott began his career in public accounting at KPMG, where he performed financial statement audits for companies in a variety of industries and identified opportunities for improved efficiencies in financial reporting, internal controls and business operations. Scott holds the designations of Certified Public Accountant (CPA) and Chartered Financial Analyst (CFA).

Scott is a member of the Family Advisory Council at New York-Presbyterian Hospital’s (NYP) Komansky Center for Children’s Health, where he also founded the Family Faculty Program, which focuses on training healthcare professionals at NYP and medical students at Weill Cornell Medical College in the concepts of Patient & Family Centered Care (PFCC). PFCC is an approach to the planning, delivery, and evaluation of health care that is grounded in mutually beneficial partnerships among health care providers, patients, and families.

Scott earned an M.B.A. from Columbia Business School and a B.S. from Bucknell University.

Schuyler Rooke

Schuyler Rooke schuyler@cheskypartners.com  https://www.linkedin.com/pub/schuyler-rooke/8a/930/60a

ANALYST

Schuyler began his career as an analyst at a NYC-based private equity firm specializing in secondary direct investments across a variety of sectors, with some emphasis on enterprise software and energy companies. Schuyler also has operating experience with MRI Interventions (OTC BB: MRIC), a micro-cap medical device company that develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural MRI guidance. While at MRI Interventions, his key focus was on technology deployment and management of active customer sites. Further, he assisted with investor relations and corporate financing efforts.

Following MRIC, Schuyler joined Poliwogg, an early stage financial services company devoted to building financial products for investment in biotech and life sciences companies. There he dedicated his time across many functions critical to expanding Poliwogg Xchange, an online direct investment platform for accredited investors as well as assisting with deployment of the company’s other innovative financial products.

Schuyler received a B.A. in Economics & English from Bucknell University.

Melissa Zoghby

Melissa Zoghby melissa@cheskypartners.com  https://www.linkedin.com/in/melissa-zoghby-cpa-78788829

ANALYST

Melissa began her career in public accounting with a regional firm in Alabama, where she performed financial statement audits primarily for middle-market companies in the Southeastern U.S. She also served as internal auditor for an NYSE listed company in the paper and packaging industry. Melissa is a Certified Public Accountant (CPA).

Melissa also has significant operating experience, having served as Chief Financial Officer of HPC Specialty Pharmacy, a specialty pharmacy headquartered in Alabama, licensed in all 50 States and focused on servicing individuals with bleeding disorders and other chronic medical conditions. While at HPC, Melissa streamlined the financial accounting and reporting processes and assisted in the strategic growth of the company through expansion into new lines of therapy and new territories. She also played an integral role in the sale of the company and was actively involved in all aspects of the deal process from preparation of marketing materials to due diligence and closing documentation.

Melissa received a B.S. in Accounting from the University of Alabama and a Master of Accountancy from the University of South Alabama.

Tony Dimun

Tony Dimun https://www.linkedin.com/pub/tony-dimun/6/313/7

SENIOR ADVISOR

Tony brings over 30 years of highly successful operational, business development, and financial experience in the healthcare marketplace. Since 2001, Tony has served as Chairman of Nascent Enterprises, LLC, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, Tony served as Executive Vice president & Chief Financial Officer of Vital Signs, Inc., a publicly held anesthesia, respiratory and sleep apnea medical device business, providing growth strategies to enhance the Company’s value through highly focused bolt on acquisitions. Vital Signs was sold to GE Medical in 2008 for $1 billion, net of $140 million cash on the balance sheet.

During the last 20 years he has been an investor and mentor to several emerging growth medical enterprises that have matured to commercial status and became publicly traded companies, acting either as the Founder or participating in the finding of 25 medical device companies. Of these enterprises, four became public companies and eleven were sold. Tony has been a director of several public companies, including, Vital Signs, Inc., Bionx Implants, Inc., Colorado MedTech Inc., Photomedix, ISS Surgical Systems and numerous privately held companies in the healthcare industry. He also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and through Nascent Enterprises provides the University of Pennsylvania and other universities with entrepreneurial assistance to commercialize Penn’s medical technology. Prior to 1991, Tony held positions as a Certified Public Accountant with national accounting firms and served as Senior VP for an international merchant banking firm specializing in mergers & acquisitions.

Zorba Lieberman

Zorba Lieberman https://www.linkedin.com/pub/zorba-lieberman/0/4bb/822

SENIOR ADVISOR

Zorba is an investor, advisor, and board member with various information-based companies serving mostly the pharmaceutical and healthcare industries. Zorba was co-founder and CEO of Citeline Inc., the leading provider of global clinical trial intelligence to the pharmaceutical industry. Zorba was recognized by PharmaVOICE as one of the industry’s top leaders in its Commanders and Chiefs edition. In the mid-1990’s, he co-founded and built Citizen 1 Software, which pioneered the effort to organize and mine business-relevant information from the Internet. Previously, Zorba was in strategic and new product planning at both Genentech and Eli Lilly, and was a management consultant at The Wilkerson Group. Zorba holds B.A. and M.B.A. degrees from Cornell University, as well as a Masters in international finance from the Université Catholique de Louvain in Belgium.

Zorba currently serves as Chairman of the Board of Directors of Pleio, Inc., a leader in medication adherence and sits on the Board of the Aquaya Institute, a non-profit research and consulting organization dedicated to improving health in the developing world through clean water innovation.

Dr. Thomas Graham

Dr. Thomas Graham https://www.linkedin.com/in/thomas-graham-a0165987

SENIOR ADVISOR

World-renowned orthopaedic hand surgeon, health care executive, author, inventor and entrepreneur, Thomas Graham, MD, is NYU Langone Health’s Director of Strategy and Innovation. In this role, Dr. Graham oversees the health system’s relationship strategies with a wide portfolio of valued partners both within and outside health care, including physicians and practices, hospitals and delivery systems, industry and the broader community. Dr. Graham also serves as Associate Chief of the Division of Hand Surgery.

Regarded a pioneer and international thought leader in medical innovation, Dr. Graham served as Cleveland Clinic’s first chief innovation officer, as well as vice chair of the Department of Orthopaedic Surgery. Earlier in his distinguished career, he was the chief of the Congressionally-designated National Hand Center in Baltimore, the largest specialty practice of its kind in the world, and held academic appointments at Johns Hopkins.

Dr. Graham has extensive clinical expertise in surgery of the hand, wrist and elbow with special concentration on complicated reconstruction after trauma, complex elbow disorders and congenital hand surgery. His practice is recognized as the premier destination for care of the professional athlete’s hand and wrist. Dr. Graham has served as the hand surgery consultant, team physician or medical director for numerous professional sports teams in the National Football League, Major League Baseball, the National Basketball Association, the National Hockey League, as well as the Professional Golfers’ Association and the Ladies Professional Golf Association.

A prolific inventor, Dr. Graham has more than 50 patents worldwide, including commonly used joint replacement systems and fracture treatment implants for the upper extremity, and has founded four medical device companies. His journey as an inventor and architect of mission-driven innovation was chronicled in his best-selling book, Innovation the Cleveland Clinic Way.

Dr. Graham has published more than 100 scholarly articles on almost every aspect of hand and upper extremity surgery, lectured widely around the world and edited several books on hand surgery and sports medicine. He was featured on ABC’s Nightline for his role in the treatment of 9/11 survivors, which was also chronicled in an exhibit at the Smithsonian Institution. He is regularly featured on the Golf Channel, ESPN and other major media and sports networks, and has been the subject of other popular media stories on local and national television. He is annually recognized by his peers in local and national publications identifying the nation’s best doctors and Who’s Who.

After earning his undergraduate degree in chemistry from Williams College, Dr. Graham received his medical degree from the University of Cincinnati College of Medicine. He completed a residency in orthopedic surgery at the University of Michigan and a fellowship in hand and upper extremity surgery at the Indiana Hand Center, with additional training in elbow surgery at Mayo Clinic. He also completed a two-year Executive Management Program in Healthcare Administration, jointly sponsored by Cleveland Clinic and the Weatherhead School of Business of Case Western Reserve University.

Start typing and press Enter to search